EUVIMEDEUVIMED entdecken
ÄquivalenzstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research

Matthew Gabel, Spondita Goswami, Semere Bekena, Erin D Solomon, Krista L Moulder, John C Morris, Jessica Mozersky iD

Alzheimer's & Dementia · 2026-05 · 22 (5)

DOI: 10.1002/alz.71356 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 05.05.2026. Verfasst von Matthew Gabel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Political Science, Washington University in St. Louis, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Patient Selection, Patient Participation. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Recruitment and retention remains a major challenge in Alzheimer's disease research. This study examined the impact of describing potential financial compensation during recruitment on participant enrollment to a longitudinal cohort. METHODS Participant recruitment calls ( N = 337) were randomized to either a compensation‐mentioned group ( n = 170) or a control group ( n = 167). An intention‐to‐treat logistic regression assessed the effect of compensation on enrollment. RESULTS Of 320 analyzed, 124 (38.75%) enrolled. The intervention group's consent rate was lower than the control group's in intention‐to‐treat (−9.72 points; p = 0.074), per‐protocol (−12.72 points; p = 0.026), and complier average causal effect analyses (−11.36 points; p = 0.72). DISCUSSION Disclosing compensation during recruitment may reduce enrollment, potentially due to perceptions that compensation conflicts with altruistic motives. However, this was observed in a highly educated sample; compensation may affect those with lower levels of education and socioeconomic status differently by helping offset participation burden, warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePatient SelectionPatient ParticipationAgedAged, 80 and overFemaleHumansMaleLongitudinal StudiesCohort StudiesSocioeconomic Factors

Stichwörter der Autor:innen

Alzheimer's diseaseeducationenrollmentfinancial compensationlongitudinal researchrecruitmentresearchretentionunderrepresented groups

Autor:innen und Institutionen

  • Department of Political Science, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Bioethics Research Center, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Knight Alzheimer Disease Research Center, Washington University in St. Louis, St. Louis, Missouri, USA.

ORCID-Profile: Jessica Mozersky

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Gabel, M., Goswami, S., Bekena, S., Solomon, E. D., Moulder, K. L., Morris, J. C., & Mozersky, J. (2026). The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research. Alzheimer's & Dementia, 22(5). https://doi.org/10.1002/alz.71356

Vancouver

Gabel M, Goswami S, Bekena S, Solomon ED, Moulder KL, Morris JC, et al. The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research. Alzheimer's & Dementia. 2026;22(5). doi:10.1002/alz.71356

BibTeX
@article{Gabel2026,
  author = {Gabel, Matthew and Goswami, Spondita and Bekena, Semere and Solomon, Erin D and Moulder, Krista L and Morris, John C and Mozersky, Jessica},
  title = {The impact of learning about financial compensation on enrollment in Alzheimer's disease longitudinal research},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {5},
  doi = {10.1002/alz.71356}
}
Kostenlos starten →